The Global Biological and Chemical Indicators Market is estimated to be valued at USD 547.9 Mn in 2025 and is expected to reach USD 851.4 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of ...

Zoltán Kaló and colleagues consider approaches to counter systemic inequities and power imbalances arising from discrete national policies for drug pricing and reimbursement Current pricing mechanisms ...

A new analysis finds medicines often are not accessible countries where they were tested before approval by the FDA, raising ...

A new Australian study has found that forms used for one of the most common genetic screening tests in pregnancy—costing ...

On November 6, 2025, the Centers for Medicare & Medicaid Services (CMS) announced a new drug payment model designed to make Most Favored ...

Tech transfer in oral solid dose (OSD) manufacturing is one of the most critical, and often underestimated, phases in the drug development lifecycle.

Uranium recoveries in the high-80-percent range and lower processing costs strengthen the Aurora Project and support Eagle’s growth into a leading domestic supplier of nuclear powerRENO, Nev., Nov. 12 ...

Early AI adoption tinkered at the edges, resulting in faster task completion within the same workflows. While this may have ...

Allied Market Research published a report, titled, "Bone Health Supplements Market by Type (Vitamins, Calcium, Collagen, Omega-3, Glucosamine, and Others), Dosage Form (Tablets, Capsules, Powder, and ...

Clinical trials are more connected and more closely examined than ever. Inspection readiness isn’t a last-minute document ...